Emergence of new clonal abnormalities (NCA) following interferon-alpha (IFN-A) complete cytogenetic response (CG-CR) in patients (pts) with chronic myelogenous leukemia (CML): Report of three cases.

被引:0
|
作者
Fayad, L [1 ]
Kantarjian, H [1 ]
OBrien, S [1 ]
Seong, D [1 ]
Albitar, M [1 ]
Keating, M [1 ]
Talpaz, M [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,HOUSTON,TX
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:929 / 929
页数:1
相关论文
共 12 条
  • [1] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases
    L Fayad
    H Kantarjian
    S O’Brien
    D Seong
    M Albitar
    M Keating
    M Talpaz
    Leukemia, 1997, 11 : 767 - 771
  • [2] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases
    Fayad, L
    Kantarjian, H
    OBrien, S
    Seong, D
    Albitar, M
    Keating, M
    Talpaz, M
    LEUKEMIA, 1997, 11 (05) : 767 - 771
  • [3] Improvement of cytogenetic response by GM-CSF in chronic myelogenous leukemia (CML) patients previously treated by interferon-alpha (IFN-A) therapy.
    Belhabri, A
    Thiebaut, A
    Thomas, X
    Charrin, C
    Michallet, M
    BLOOD, 2000, 96 (11) : 252B - 253B
  • [4] Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia
    Maloisel, F
    Uettwiller, F
    Laplace, A
    Lioure, B
    Herbrecht, R
    Mark, M
    Dufour, P
    CANCER GENETICS AND CYTOGENETICS, 1999, 113 (02) : 172 - 176
  • [5] PREDICTING COMPLETE CYTOGENETIC RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH RECOMBINANT INTERFERON-ALPHA
    MAHON, FX
    MONTASTRUC, M
    FABERES, C
    REIFFERS, J
    BLOOD, 1994, 84 (10) : 3592 - 3594
  • [7] ALPHA-INTERFERON (IFN) RESULTS IN HIGH COMPLETE CYTOGENETIC RESPONSE RATE IN PATIENTS WITH CYTOGENETIC-ONLY RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER MARROW TRANSPLANTATION (BMT)
    HIGANO, C
    RASKIND, W
    FLOWERS, M
    BLOOD, 1993, 82 (10) : A169 - A169
  • [8] Interferon-Alpha (IFN-a) Is Able To Maintain Complete Molecular Response (CMR) In Chronic Myeloid Leukemia (CML) Patients Who Maintain Undetectable disease After Imatinib (IM) Discontinuation
    Carella, Angelo Michele
    Beltrami, Germana
    Ghiggi, Chiara
    BLOOD, 2013, 122 (21)
  • [9] Ph plus chronic myelogenous leukemia (CML):: Reverse quantitative polymerase chain reaction (RQ-PCR) for monitoring of patients aged <20 years in complete cytogenetic response (CCR) following interferon-alpha (IFN).
    Giona, F
    Fava, M
    Moleti, ML
    Gottardi, E
    Diverio, D
    Alfieri, C
    De Cuia, MR
    Testi, AM
    Saglio, G
    Mandelli, F
    Foa, R
    BLOOD, 2003, 102 (11) : 316B - 316B
  • [10] The long term outcome of the patients with chronic myeloid leukemia (CML) who have achieved complete cytogenetic response (CCgR) to interferon-α (IFNα).: A collaborative European study of 317 cases.
    Bonifazi, F
    De Vivo, A
    Rosti, G
    Guilhot, F
    Guilhot, J
    Trabacchi, E
    Hehlmann, R
    Hochhaus, A
    Shepherd, P
    Steegmann, JL
    Kluin-Nelemans, HC
    Thaler, J
    Simonsson, B
    Louwagie, A
    Reiffers, J
    Mahon, FX
    Montefusco, E
    Alimena, G
    Hasford, J
    Richards, S
    Saglio, G
    Testoni, N
    Martinelli, G
    Tura, S
    Baccarani, M
    BLOOD, 2001, 98 (11) : 348A - 348A